Looking to publish in Med? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowMed is a monthly clinical and translational research journal published by Cell Press. It publishes original research, Reviews, and Perspective articles across the translational and clinical continuum, including clinical studies, translational research, biotechnology and engineering advances with clinical impact, and medical resources spanning areas such as cancer, cardiovascular and metabolic disease, immunology, infectious diseases, neurology, genetics, and public health.
Looking to publish in Med? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Med accepts the following article types. Click on an article type to view submission instructions.
Articles
Resources
Review
Reports
Case Reports
Correspondences
Perspective
Recent Publications
Expansion of NKG2A+CD8+ T cells with regulatory signatures distinguish individuals living with HIV-2 from those with HIV-1
Aurelio Orta Resendiz, Caroline Petitdemange, Marie Lazzerini, Béatrice Jacquelin, Emma Beaumont, Federico Perdomo-Celis, Assia Samri, Olivier Lambotte, Laurence Meyer, Cecile Goujard, Florence Damond, Diane Descamps, Charlotte Charpentier, Jade Ghosn, Nicolas Huot, Michaela Müller-Trutwin
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)
Jianwei Zhang, Sifan Qi, Huabin Hu, Xiaosheng He, Liang Huang, Jiaming Zhou, Hui Wang, Xiaojian Wu, Liang Kang, Meijin Huang, Zhen He, Huaiming Wang, Dianke Chen, Xiaohui Zhai, Xiaoyu Xie, Jiayu Ling, Yan Zhang, Jiancong Hu, Shanshan Li, Zehua Wu, Tao Yang, Runkai Cai, Yue Cai, Lixing Zhong, Weiwei Li, Lishuo Shi, Chao Wang, Yan Huang, Yandong Zhao, Wuteng Cao, Ge Qin, Yanhong Deng
Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapy
Xudong Ni, Yufan Zhao, Shanshan Wang, Lei Zhong, Xuedong Shi, Xiaomeng Li, Qi Ma, Yi Wu, Dingwei Ye, Yao Zhu
NSCLC: Five trials to watch
Wei-Chi Luo, Shu-Xin Zhong, Si-Yang Maggie Liu, Yi-Long Wu
Rethinking the role of synergy calculations in the next century of drug combination discovery
Christian T. Meyer, Yunxing Dai, Amy E. Pomeroy, Nathaniel R. Twarog, Andreas Bender, Steven S. Rosenfeld, Emmanuel S. Antonarakis, Jerome T. Mettetal, R. Stephanie Huang, Vito Quaranta, Jing Tang, Anang A. Shelat, Malcolm A. Smith, Adam C. Palmer
Frequently asked questions
How long does it take to publish?
2 days from submission to first decision; 64 days from submission to acceptance.
Reformat to Med using Livewrite PremiumIs a cover letter required?
A cover letter is included among the materials to prepare for submission. A cover letter or point-by-point response is also requested for final submission.
Reformat to Med using Livewrite PremiumWhat are the publication costs?
There is no fee to publish under the default subscription model. Open access is available for most article types, with APC charges provided through the Cell Press open access program.
Reformat to Med using Livewrite Premium